We have identified a more suitable language of this document. To change language to please click here or close
Wir haben eine besser geeignete Sprache dieses Dokuments identifiziert. Um die Sprache auf zu ändern, klicken Sie bitte hier oder hier um diese Meldung zu schließen.
We have identified a more suitable language of this document. To change language to please click here or close
Hemos identificado un lenguaje más adecuado de este documento. Para cambiar el idioma a haga clic aquí o cerrar
我们已为您显示此文档的最佳语言。请点击此处 将语言更改为 或者 关闭
Abbiamo identificato un'altra lingua per questo documento. Per modificare la lingua in fare clic qui o chiudere
For storing your preferred location, analysing referrals from LinkedIn and embedding third party content we need your consent (which you can withdraw any time).
This website uses cookies so that we can provide you with the best user experience possible. Our Cookie Notice is part of our Privacy Policy and explains in detail how and why we use cookies. To take full advantage of our website, we recommend that you click on “Accept All”. You can change these settings at any time via the button “Update Cookie Preferences” in our Cookie Notice.
Technical cookies (required)
Technical cookies are required for the site to function properly, to be legally compliant and secure. Session cookies only last for the duration of your visit and are deleted from your device when you close your internet browser. Persistent cookies, however, remain and continue functioning on repeat visits.
Analytics
We does not use any cookie based Analytics or tracking on our websites; see details here.
Personalisation cookies
Personalisation cookies collect information about your website browsing habits and offer you a personalised user experience based on past visits, your location or browser settings. They also allow you to log in to personalised areas and to access third party tools that may be embedded in our website. Some functionality will not work if you don’t accept these cookies.
The CMS Corporate/M&A group is pleased to launch the eleventh edition of our European M&A Study.
We are currently experiencing some technical issues with our video content hosting.
Please bear with us and we will have our video content back online soon.
This year’s Study reflects data from 458 deals in 2018 on which CMS advised. This is the largest number of deals ever covered by the Study, now in its 11th year, which is reflective of CMS’s gain in market share and corresponding rise up the M&A league tables. In analysing the 2018 market, we report on current market standards on risk allocation in M&A deals, comparing 2018 against 2017 and the previous eight-year average for 2010 – 2017.
The special features of the Study are as follows:
CMS Trend Index – to illustrate a current fact or trend for the particular feature reported on, comparing the position in 2018 with that of 2017 and / or the eight-year period 2010 – 2017.
CMS European / US risk allocation comparison – a headline analysis of the differing risk allocation on standard issues in European and US M&A.
CMS European regional differences – we highlight certain issues which are particular to one or more of the six European regions covered.
CMS deal size analysis – we analysed our data against three different deal values: deals up to EUR 25m; EUR 25m to 100m and deals exceeding EUR 100m.
For the first time, the Study sought to evaluate the main deal driver for each transaction reviewed. This is in addition to analysis of the background of the seller (mostly strategic and finance investors but also a substantial number of individuals) and the buyer (almost exclusively strategic and finance investors).
The key findings of the Study include:
Decreased use of purchase price adjustments (PPA) – around 44 percent of deals included a PPA compared with 48 percent in 2017. This represents a notable movement against the overall trend in recent years
Significant increase in the application of locked box structures – of the deals that did not involve a PPA, 59 percent used a locked box in 2018 which represents a significant increase over the 49 percent in 2017
Earn-outs continue to grow in popularity – there was a two-percentage point year on year increase in the use of earn-outs in 2018. A quarter of small and mid-cap deals now involve earn-outs
A record year for Warranty & Indemnity (W&I) insurance –sellers are increasingly offloading their warranty exposure by pre-packaging a buyer’s W&I policy. Nearly a third (30 percent) of deals valued over EUR 100m now involve this form of insurance
We trust that the CMS European M&A Study will assist you in your everyday M&A activities.
If you want to use third party tools, please enable personalisation cookies as part of your cookie preferences. You can change this setting at any time via the button below or in our Cookie Notice.
March 2019
The CMS Corporate/M&A group is pleased to launch the eleventh edition of our European M&A Study.
Please bear with us and we will have our video content back online soon.
This year’s Study reflects data from 458 deals in 2018 on which CMS advised. This is the largest number of deals ever covered by the Study, now in its 11th year, which is reflective of CMS’s gain in market share and corresponding rise up the M&A league tables. In analysing the 2018 market, we report on current market standards on risk allocation in M&A deals, comparing 2018 against 2017 and the previous eight-year average for 2010 – 2017.
The special features of the Study are as follows:
For the first time, the Study sought to evaluate the main deal driver for each transaction reviewed. This is in addition to analysis of the background of the seller (mostly strategic and finance investors but also a substantial number of individuals) and the buyer (almost exclusively strategic and finance investors).
The key findings of the Study include:
We trust that the CMS European M&A Study will assist you in your everyday M&A activities.